Sandoz reaches $400 million tentative settlement with Wisconsin, other states
A generic drugmaker reached a $400 million tentative settlement with Wisconsin and other states to resolve allegations it engaged in anticompetitive behavior.
To access this content, you must purchase a Premium membership, or log in if you are a member.